Literature DB >> 22204021

Eph-dependent cell-cell adhesion and segregation in development and cancer.

Eva Nievergall1, Martin Lackmann, Peter W Janes.   

Abstract

Numerous studies attest to essential roles for Eph receptors and their ephrin ligands in controlling cell positioning and tissue patterning during normal and oncogenic development. These studies suggest multiple, sometimes contradictory, functions of Eph-ephrin signalling, which under different conditions can promote either spreading and cell-cell adhesion or cytoskeletal collapse, cell rounding, de-adhesion and cell-cell segregation. A principle determinant of the balance between these two opposing responses is the degree of receptor/ligand clustering and activation. This equilibrium is likely altered in cancers and modulated by somatic mutations of key Eph family members that have emerged as candidate cancer markers in recent profiling studies. In addition, cross-talk amongst Ephs and with other signalling pathways significantly modulates cell-cell adhesion, both between and within Eph- and ephrin-expressing cell populations. This review summarises our current understanding of how Eph receptors control cell adhesion and morphology, and presents examples demonstrating the importance of these events in normal development and cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22204021     DOI: 10.1007/s00018-011-0900-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  373 in total

1.  Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans.

Authors:  Peter W Janes; Nayanendu Saha; William A Barton; Momchil V Kolev; Sabine H Wimmer-Kleikamp; Eva Nievergall; Carl P Blobel; Juha-Pekka Himanen; Martin Lackmann; Dimitar B Nikolov
Journal:  Cell       Date:  2005-10-21       Impact factor: 41.582

2.  Autoregulation by the juxtamembrane region of the human ephrin receptor tyrosine kinase A3 (EphA3).

Authors:  Tara L Davis; John R Walker; Peter Loppnau; Christine Butler-Cole; Abdellah Allali-Hassani; Sirano Dhe-Paganon
Journal:  Structure       Date:  2008-06       Impact factor: 5.006

3.  Receptor tyrosine kinase EphB4 is a survival factor in breast cancer.

Authors:  S Ram Kumar; Jasbir Singh; Guangbin Xia; Valery Krasnoperov; Loubna Hassanieh; Eric J Ley; Jeffrey Scehnet; Neil G Kumar; Debra Hawes; Michael F Press; Fred A Weaver; Parkash S Gill
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

Review 4.  Regulation of protein tyrosine phosphatases by reversible oxidation.

Authors:  Arne Ostman; Jeroen Frijhoff; Asa Sandin; Frank-D Böhmer
Journal:  J Biochem       Date:  2011-08-19       Impact factor: 3.387

5.  EphrinA1 inactivates integrin-mediated vascular smooth muscle cell spreading via the Rac/PAK pathway.

Authors:  Christophe Deroanne; Valérie Vouret-Craviari; Bingcheng Wang; Jacques Pouysségur
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

6.  Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells.

Authors:  N W Gale; P Baluk; L Pan; M Kwan; J Holash; T M DeChiara; D M McDonald; G D Yancopoulos
Journal:  Dev Biol       Date:  2001-02-15       Impact factor: 3.582

7.  Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development.

Authors:  Chad A Cowan; Nobuhiko Yokoyama; Ankur Saxena; Michael J Chumley; Robert E Silvany; Linda A Baker; Deepak Srivastava; Mark Henkemeyer
Journal:  Dev Biol       Date:  2004-07-15       Impact factor: 3.582

8.  Genetic alterations in the tyrosine kinase transcriptome of human cancer cell lines.

Authors:  Jens E Ruhe; Sylvia Streit; Stefan Hart; Chee-Hong Wong; Katja Specht; Pjotr Knyazev; Tatjana Knyazeva; Liang Seah Tay; Hooi Linn Loo; Priscilla Foo; Winnie Wong; Sharon Pok; Shu Jing Lim; Huimin Ong; Ming Luo; Han Kiat Ho; Kaitian Peng; Tze Chuen Lee; Martin Bezler; Christian Mann; Silvia Gaertner; Heinz Hoefler; Stefano Iacobelli; Stephan Peter; Alice Tay; Sydney Brenner; Byrappa Venkatesh; Axel Ullrich
Journal:  Cancer Res       Date:  2007-12-01       Impact factor: 12.701

9.  EphB signaling directs peripheral nerve regeneration through Sox2-dependent Schwann cell sorting.

Authors:  Simona Parrinello; Ilaria Napoli; Sara Ribeiro; Patrick Wingfield Digby; Marina Fedorova; David B Parkinson; Robin D S Doddrell; Masanori Nakayama; Ralf H Adams; Alison C Lloyd
Journal:  Cell       Date:  2010-10-01       Impact factor: 41.582

10.  Regulation of EphB2 activation and cell repulsion by feedback control of the MAPK pathway.

Authors:  Alexei Poliakov; Maria L Cotrina; Andrea Pasini; David G Wilkinson
Journal:  J Cell Biol       Date:  2008-12-01       Impact factor: 10.539

View more
  47 in total

Review 1.  Therapeutic targeting of EPH receptors and their ligands.

Authors:  Andrew W Boyd; Perry F Bartlett; Martin Lackmann
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

2.  KSR1 and EPHB4 Regulate Myc and PGC1β To Promote Survival of Human Colon Tumors.

Authors:  Jamie L McCall; Drew Gehring; Beth K Clymer; Kurt W Fisher; Binita Das; David L Kelly; Hyunseok Kim; Michael A White; Robert E Lewis
Journal:  Mol Cell Biol       Date:  2016-08-12       Impact factor: 4.272

3.  Antibodies binding the ADAM10 substrate recognition domain inhibit Eph function.

Authors:  Lakmali Atapattu; Nayanendu Saha; Carmen Llerena; Mary E Vail; Andrew M Scott; Dimitar B Nikolov; Martin Lackmann; Peter W Janes
Journal:  J Cell Sci       Date:  2012-10-29       Impact factor: 5.285

Review 4.  Eph- and ephrin-dependent mechanisms in tumor and stem cell dynamics.

Authors:  Erika Gucciardo; Nami Sugiyama; Kaisa Lehti
Journal:  Cell Mol Life Sci       Date:  2014-05-04       Impact factor: 9.261

5.  EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma.

Authors:  Mehdi Farshchian; Liisa Nissinen; Elina Siljamäki; Pilvi Riihilä; Mervi Toriseva; Atte Kivisaari; Risto Ala-Aho; Markku Kallajoki; Esko Veräjänkorva; Hanne-Kaisa Honkanen; Ritva Heljasvaara; Taina Pihlajaniemi; Reidar Grénman; Juha Peltonen; Sirkku Peltonen; Veli-Matti Kähäri
Journal:  J Invest Dermatol       Date:  2015-03-19       Impact factor: 8.551

6.  EphA4-mediated signaling regulates the aggressive phenotype of irradiation survivor colorectal cancer cells.

Authors:  Priscila Guimarães de Marcondes; Lilian Gonçalves Bastos; Julio Cesar Madureira de-Freitas-Junior; Murilo Ramos Rocha; José Andrés Morgado-Díaz
Journal:  Tumour Biol       Date:  2016-06-21

Review 7.  Eph/ephrin recognition and the role of Eph/ephrin clusters in signaling initiation.

Authors:  Dimitar B Nikolov; Kai Xu; Juha P Himanen
Journal:  Biochim Biophys Acta       Date:  2013-04-26

Review 8.  Cell mates: paracrine and stromal targets for prostate cancer therapy.

Authors:  Pavel Sluka; Ian D Davis
Journal:  Nat Rev Urol       Date:  2013-07-16       Impact factor: 14.432

9.  EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells.

Authors:  Francesco La Rocca; Irma Airoldi; Emma Di Carlo; Pina Marotta; Geppino Falco; Vittorio Simeon; Ilaria Laurenzana; Stefania Trino; Luciana De Luca; Katia Todoerti; Oreste Villani; Martin Lackmann; Fiorella D'Auria; Francesco Frassoni; Antonino Neri; Luigi Del Vecchio; Pellegrino Musto; Daniela Cilloni; Antonella Caivano
Journal:  Cell Oncol (Dordr)       Date:  2017-07-18       Impact factor: 6.730

10.  One-Bead-Two-Compound Thioether Bridged Macrocyclic γ-AApeptide Screening Library against EphA2.

Authors:  Yan Shi; Sridevi Challa; Peng Sang; Fengyu She; Chunpu Li; Geoffrey M Gray; Alekhya Nimmagadda; Peng Teng; Timothy Odom; Yan Wang; Arjan van der Vaart; Qi Li; Jianfeng Cai
Journal:  J Med Chem       Date:  2017-11-14       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.